WuXi STA launched its first high potency (HP), automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new HP injectable manufacturing line, with an annual capacity of 12 million units, enhances manufacturing capabilities and capacity for injectable dosage forms.   The new line meets Occupational Exposure Limits (OEL) as low as 10 ng/m3 and utilizes fully enclosed isolation systems and automated filling machines. This design minimizes human interventio...